A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

Giampietro Gasparini; Francesco Torino; Takayuki Ueno; Stefano Cascinu; Teresa Troiani; Alberto Ballestrero; Rossana Berardi; Junichi Shishido; Akihiko Yoshizawa; Yukiko Mori; Satoshi Nagayama; Paola Morosini; Masakazu Toi

doi:10.1007/s10456-011-9250-0

JOURNAL ARTICLE

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

Giampietro Gasparini Francesco Torino Takayuki Ueno Stefano Cascinu Teresa Troiani Alberto Ballestrero Rossana Berardi Junichi Shishido Akihiko Yoshizawa Yukiko Mori Satoshi Nagayama Paola Morosini Masakazu Toi

Year: 2012 Journal: Angiogenesis Vol: 15 (1)Pages: 141-150 Publisher: Springer Science+Business Media

DOI: 10.1007/s10456-011-9250-0

Get Full-Text PDF Get Analytical Report

Keywords:

Medicine Capecitabine Bevacizumab Neoadjuvant therapy Colorectal cancer Radiation therapy Internal medicine Cancer Gastroenterology Proctitis Oncology Chemotherapy Breast cancer Disease

Metrics

Cited By

3.75

FWCI (Field Weighted Citation Impact)

Refs

0.93

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Colorectal Cancer Surgical Treatments

Health Sciences → Medicine → Oncology

Colorectal and Anal Carcinomas

Health Sciences → Medicine → Surgery

Colorectal Cancer Treatments and Studies

Health Sciences → Medicine → Oncology

Related Documents

JOURNAL ARTICLE

Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study

Kiyoshi Maeda Masatsune Shibutani Hiroshi Otani Tatsunari Fukuoka Yasuhito Iseki Shinji Matsutani Hisashi Nagahara Toru Inoue Akiko Tachimori Takafumi Nishii Yoshitaka Miki Masako Hosono Masaichi Ohira

Journal: Anticancer Research Year: 2018 Vol: 38 (7)Pages: 4193-4197

JOURNAL ARTICLE

Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer

Christopher H. Crane Cathy Eng Barry W. Feig Prajnan Das John M. Skibber George J. Chang Robert A. Wolff Sunil Krishnan Stanley R. Hamilton Nora A. Janjan Dipen M. Maru Lee M. Ellis Miguel A. Rodrı́guez-Bigas

Journal: International Journal of Radiation Oncology*Biology*Physics Year: 2009 Vol: 76 (3)Pages: 824-830

JOURNAL ARTICLE

Triweekly XELOX Versus Single Capecitabine Concomitant with Neoadjuvant Radiotherapy for Locally Advanced Rectal Cancer

A. Li Benhua Xu

Journal: International Journal of Radiation Oncology*Biology*Physics Year: 2020 Vol: 108 (3)Pages: e658-e658

JOURNAL ARTICLE

Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single‐institute phase II study

Xin Yu Qiaoxuan Wang Weiwei Xiao Hui Chang Zhifan Zeng Zhen-Hai Lu Xiaojun Wu Gong Chen Zhizhong Z. Pan De-Sen Wan Peirong Ding Yuanhong Gao

Journal: Cancer Communications Year: 2018 Vol: 38 (1)Pages: 1-9

JOURNAL ARTICLE

Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC)

Guobang Shi E. Lin Cathy Eng M. Delcos Christopher H. Crane A. Shiver T.D. Brown J. L. Abbruzzese J. M. Skibber Nora A. Janjan

Journal: Journal of Clinical Oncology Year: 2004 Vol: 22 (14_suppl)Pages: 3775-3775